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A new strategy is reported for extracting complete and partial sequence information from 
collision-induced dissociation (CID) spectra of peptides. CID spectra are obtained from high 
energy CID of peptide molecular ions on a four-sector tandem mass spectrometer with an 
electro-optically coupIed microchannel array detector. A peak detection routine reduces the 
spectrum to a list of peak masses and peak heights, which is then used for sequencing. The 
sequencing algorithm was designed to use spectral data to generate sequence fits directly 
rather than to use data to test the ht of series of sequence guesses. The peptide sequencing 
algorithm uses a pattern based on the polymeric nature of peptides to classify spectral 
peaks into sets that are related in a sequence-independent manner. It then establishes 
sequence relationships among these sets. Peak detection from raw data takes lo-20 s, with 
sequence generation requiring an additional lo-60 s on a Sun 3/6O workstation. The 
program is written in the C language to run on a Unix platform. The principal advantages 
of our method are in the speed of analysis and the potential for identifying modified or rare 
amino acids. The algorithm was designed to permit real-time sequencing but awaits 
hardware modifications to allow real-time access to CID spectra. (1 Am Sot Mass Spectmm 
1992, 3, 326-336) 
P 
rotein sequence analysis plays an integral role 
in protein chemistry. It is used to give molecu- 
lar identity to unknown proteins, such as a spot 
from a two-dimensional gel [l] or an isolated fraction 
with a specific activity. It can provide short sequences 
for the construction of oligonucleotide probes for gene 
cloning [2,3] and can verify the structure of expressed 
proteins [4]. Such analysis not only discovers infor- 
mation with intrinsic value, but is also a prerequisite 
to further higher order structural characterization by 
such techniques as x-ray crystallography or nuclear 
magnetic resonance. Mass spectrometrists have long 
been interested in protein sequence analysis [5], but 
recently researchers interested in peptides and pro- 
teins have become interested in mass spectrometry as 
an alternative means for analyzing peptide primary 
structure. This new interest goes beyond the vital role 
mass spectrometry has played in the analysis of post- 
translationally modtied proteins [6] and can, in part, 
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be attributed to the combination of single ion detec- 
tion limits [7j and array detection in tandem four-sec- 
tor instruments [7-lo]. Advances in ionization meth- 
ods, such as electrospray [ll-131 and matrix-assisted 
laser desorption [14, 151, combined with advanced 
tandem instrumentation, will further the promise of 
rapid, high sensitivity mass spechomehic sequencing. 
Two mass spectrometric approaches are currently 
used in peptide sequencing. Both are known as tan- 
dem mass spectrometry (MS/MS) but are distinctly 
different in the mass analyzers employed and the 
modes of fragmentation typically observed. “Low en- 
ergy collision-induced dissociation (CID)” is typically 
practiced on triple quadrupole or hybrid mass spec- 
trometers and results in a smaller set of observed 
sequence ions compared with “high energy CID,” 
which generally requires sector based instrumenta- 
tion. (Detailed comparisons have been reported re- 
cently [16, 171.) Computer-assisted strategies For ana- 
lyzing low energy CID spectra of peptides have been 
reported [l&l. 
Modern tandem double focusing mass spectrome- 
ters use the first mass spectrometer to select an iso- 
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topically pure molecular ion, a gas cell to collisionally 
energize the incident ions, the second mass spectrom- 
eter to mass analyze the resulting fragments, and an 
electro-optically coupled microchannel plate array for 
detection within a pseudofocal plane that may cover a 
4% to -20% mass range at nominal mass resolution 
[9, 191. By using this technology tandem spectra can 
now be obtained in minutes on picomole amounts of 
cycle [23], while acquisition of a complete CID spec- 
trum of a peptide of M, - 1500 (-12-16 residues) 
takes less than 5 min. Unfortunately, at this stage 
interpretation of peptide fragment ion spectra can 
require hours to days of an expert’s time. 
Interpretation of a mass spectrum is accomplished 
either by (1) correlation of observed fragments with 
those predicted from a postulated sequence and em- 
peptides from mixtures such as enzymatic proteolysis pirically derived fragmentation rules, or by (2) build- 
fragments. ing sequences from among the possible interpre- 
The task of protein sequence analysis is to deter- tations of the fragments observed. The difference 
mine the ordered series of amino acids that comprise between these two approaches is that the latter uses 
a peptide chain. Certain characteristics of peptides, mass spectral data to generate sequence, whereas the 
relative to other classes of organic molecules, simplii former merely tests a series of postulated sequences 
their structural characterization by mass spectrome- and their predicted spectra for fit to data. An impor- 
try. Genetically encoded peptides and proteins are tant variant of correlation methods is the partial corre- 
linear, and amino acids linked by peptide bonds lation method [20, 241 in which spectra are predicted 
maintain a consistent N- to C-terminal orientation. based on a limited guess (such as a C-terminal amino 
The genetically encoded alphabet consists of onl 
Y 
acid) and evaluated for fit to data. If a partial se- 
twenty residues, two pairs of which are isobaric . quence guess passes a discrimination step, it then 
While these factors aid in structural identification, becomes a “seed” for subsequent extension by one or 
sequencing remains a challenge because there are 20” 
sequences of peptides n residues long. This translates 
to greater than 2 x 107 possible sequences of nominal 
mass 800 u [ZO]. Consideration of modified amino 
acids increases complexity and counters the advan- 
tages conferred by genetically encoded compositions. 
Still, identification of modified ammo acids remains a 
major strength of mass spectral techniques [6]. 
Mass spectromeby has several advantages over 
conventional sequencing: the ability to analyze rare or 
modified amino acids, superior performance on mix- 
tures, and speed of analysis. Automated Edman 
degradation, the most widespread method of acquir- 
ing sequence data, typically utilizes chromatographic 
methods to separate and identify the amino acids 
derived from the peptide or protein being degraded. 
Identification of each residue is based on comparison 
to the retention time of a standard, and explicit prepa- 
ration for nonstandard residues is required 1211. In 
contrast, mass spectrometry does not require advance 
preparation for the identihcation of novel residues 
prior to data collection [22]. One important class of 
modifications to peptides and proteins is N-terminal 
blocking groups that prevent direct Edman sequenc- 
ing but cause little problem to mass spectrometric 
methods beyond consideration during spectral inter- 
pretation. Mixtures are extremely difficult and often 
impossible to deconvolute in chemical sequencing ex- 
periments, whereas MS/MS employs an initial gas- 
phase separation based on mass-to-charge ratios that 
eliminates the need for complete purification in most 
cases. Edman degradation takes ‘30 min to 1 h per 
two amino acids. This process is repeated- until a 
sequence guess meets (is reported) or exceeds (is 
discarded) the mass of the protonated peptide. The 
occurrence of an unexpected residue (not part of the 
guessing algorithm) precludes successful interpreta- 
tion by such an algorithm. Inclusion of additional 
residue masses increases analysis time. 
The second approach, building sequences directly 
from the data, is the one we have undertaken and is 
the subject of this article. Our method’s principal 
advantages are its potential to discover unanticipated 
answers and its reliance on the CID spectra them- 
selves as the initiators of sequence assignment. It 
should also have advantages in speed and in the 
ability to yield partial sequences from spectra even 
when complete sequencing may not be possible, ei- 
ther because the present algorithm is not optimal or 
because the necessary information is not contained in 
the spectrum. One difficulty with both kinds of corre- 
lation schemes arises from inexperience with the pat- 
terns found within CID spectra. It is currently impos- 
sible to predict confidently the complete high energy 
CID spectrum expected from a given amino acid se- 
quence, making correlation of predicted sequences 
problematic. We therefore propose to develop and 
implement not only algorithms to extract sequence 
information, but also tools that will eventually gener- 
ate rules describing the expected observable sequence 
ions, maximizing our ability to discriminate between 
candidate sequences. An ultimate goal of this work is 
to provide accurate data reduction in real time so as to 
fully complement mass spectrometry’s inherent speed 
of analysis. 
1 Two amino acids, leucine and isoleucine, are isomeric but may be 
distinguished by side chain fragmentations that are frequently ok- 
served under high collision energy regimes [28-301. The remaining 
isobaric pair, lysine and dutamine, requires further information, but 
often i&reeren&s may g made baseb on sample origin and the 
expected effects of the basic amino group of lysine on obsewable 
fragment ions. Definitive results are obtainable by acetylation. 
Method 
Our MS/MS instrumentation (Kratos Concept BHH, 
Manchester, UK) is of four-sector EBEB geometry with 
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a gas collision cell between the two double focusing 
mass spectrometers, as described in detail elsewhere 
[lo]. Peptides are dissolved in a liquid matrix and 
sputtered with a Cs+ ion beam. The most commonly 
used matrices are glycerol/thioglycerol (1:l or 21, 
with or without acidification), nitrobenzyl alcohol, 
and dithiothreitol:dithioerythritol mixture (4:l). The 
first double focusing mass spectrometer selects and 
transmits a single isotopic species into the collision 
cell. Fragment ions are produced by CID with He in 
the gas cell. The collision cell potential can be varied, 
but for most of these experiments it was set to give a 
collision energy of 4 keV. Fragments from singly 
charged parents are mass analyzed by MS-II and 
detected on an electro-optically coupled microchannel 
array that simultaneously detects masses over a 4% 
range with a typical resolution of 1500. Channel/array 
data are saved on computer (Eclipse S280) and trans- 
ferred via ethernet to a Sun 3/60 (Sun Microsystems, 
Mountain View, CA) for analysis and storage on hard 
disk. 
Programs have all been written in the C program- 
ming language using the standard compiler supplied 
with Sun Unix version 4.01. Initial programs were 
also developed in C on a Macintosh computer using 
Think C version 4.0 (Symantec, Cupertino, CA). An 
interactive graphical learning tool that helps a novice 
visualize sequence choices and utilizes a color Macin- 
tosh display will be described elsewhere. 
Peptides employed in this study were most often 
obtained from specific enzymatic proteolysis of pro- 
teins, followed by partial purification by reverse phase 
high-performance liquid chromatography [25]. Other 
sources include isolates of bioactive peptides from 
amphibian skin secretions [B. Gibson, unpublished 
data], synthetic peptides, and chemically derivatized 
peptides of various origins. The peptide spectra ana- 
lyzed represent the efforts of many investigators 
working within the UCSF Mass Spectrometry Facility 
who have generously allowed the use of their unpub- 
lished data. 
A peak detection routine was written specifically 
for this work to generate a reliable set of peak mass 
and peak height values from raw data. Our peak 
detection scheme seeks local maxima with “reason- 
able” peak shape, as defined by the local slope one 
channel each to the left and right of the peak top as a 
percent of peak height. It alerts the operator to ques- 
tionable peak shapes or masses inconsistent with usual 
peptide accurate masses. This routine saves the n 
most abundant peaks, where II is either user-specified 
or 10% of the precursor mass (default). The number of 
peaks is intentionally chosen large to include many 
seemingly insignificant peaks. Mass and peak height 
values are recorded for these peaks and stored as an 
ASCII hle. Peak height is reported in millivolts, the 
same scaling presented in the Mach3 (Kratos) raw 
data package, Actual sequencing algorithms use this 
list of ion masses and peak heights, with one impor- 
tant modification, to produce hles with complete and 
partial interpretations of spectra. All masses are ini- 
tially recorded with 0.01 u precision and typically 
better than 4.2 u accuracy, but are converted to 
nominal mass within the sequencing algorithm. The 
conversion applies a correction factor of 0.9995 (the 
reciprocal of the typical peptide mass excess) and then 
rounds to the nearest integer. Thus, 1000.49 becomes 
1000 and 2001.13 becomes 2000. Conversion to nomi- 
nal mass speeds and simplihes further comparison 
between masses. This conversion does not lose sig- 
nificant information as peptide mass excess (as a per- 
cent of peptide mass) shows little variation. The table 
of peaks can be edited manually to correct for improp- 
erly calibrated data, separately from the sequencing 
program, although this has seldom proved necessary. 
Sequencing Algorithm 
Fragment ions from peptide molecular ions have been 
characterized and a suitable nomenclature has been 
established [26]. More than twenty [27] different ion 
types have been described thus far for high energy 
collisions and a subset of these is also present in low 
energy CID spectra [16]. Most of these ions are of 
potential use in strategies designed to turn peptide 
tandem mass spectra into amino acid sequences. The 
types of ions used in our algorithm are the six peptide 
backbone cleavage products (a, b, c, x, y, and z + 1) 
and three resulting from important side chain losses 
(d, v, and w) [27-301. The single amino acid immo- 
nium ions are also used to restrict the amino acid 
compositions considered by classifying each amino 
acid as allowed, required, or excluded [31]. 
Table 1 lists the ions used in our algorithm along 
with formulas for calculating their masses. These for- 
mulas may be rewritten to describe all ions based on a 
single sequence-ion type. In our case we have chosen 
the y type ion as shown in Figure 1. (Two values of w 
ions are currently matched with R, as l-I and CH,.) 
This pattern is used to find sets of potentially related 
Table 1. Principal ions used in the algorithm with formulae 
for calculating ion masses based on known sequence 
TYPO Simple structure 
+INH, = CHIRII 
INH,CH(R)COl+ 
+HINH,CH0WXNH,I 
+[NH,CHFKONHCHR,I 
+[NHZCHCONHCH~RICOOH1 
+[R,HC = CHNHCHIRKOOHI 
+[CONHCHFiKOOHI 
+[NH,CH(RKOOHl 
+H[NH = C(RKOOH1 
+H[CH(RKOOHI 
Generic formula 
Caa, - 27 
Cm + 1 
Caa, + 18 
xaa, + 43 + R, 
Caa, + 74 
Xaa, + 72 + R, 
&a, + 47 
Xaa, + 19 
Caa, + 17 
zaa, + 2 
Substituents R. on cl and w ions are normally l-l for aminp acids 
that are not branched at the beta carbon. Other possiblllties are 
CH3 for Val. Thr. and Ile, as well as OH for Thr and C,H, for 
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Figure 1. The set of ions that comprises an ion family. Algebraic relationships between individual 
sequence ions are shown. R, is taken as H for this hgure. Currently, our algorithm also allows for 
R, as CH, for w ions but distinguishes this ion in y-certter and link reports by using uppercase (W). 
It should be further noted that the nomenclature used in our program differs from that proposed by 
Biemann and co-workers [28], labeling z, + 1 simply as z. This is in keeping with the goal of 
simplifying the nomenclature to refer to the most commonly observed ion, as has been done with y 
and c ions. For this article we have used the z, f 1 nomenclature except in Figure 4, where the +l 
has been omitted to alleviate clutter. 
ions. These rdationships are independent of specific 
amino acid sequence and instead derive from the 
repetitive polymeric nature of the peptides. The pat- 
tern matching approach capitalizes on the redundant 
sequence information present in high energy CID 
spectra to reinforce a common signal and is the cor- 
nerstone of our algorithm. 
There are three distinct steps in our sequencing 
routine: transformation, linking, and sequence trac- 
ing. The transformation step begins with the mass of 
the most abundant ion in our analysis set. This mass 
is used as a “seed ion” to generate an ion matrix like 
that shown in Table 2. The matrix is generated by 
postulating the seed ion as each ion type and calculat- 
ing the related ions’ masses’ from the formulas pre- 
sented in Figure 1. Each “ion family” (an ion family 
is a row within the matrix) is then scored by the 
number of experimental matches and the sum of their 
corresponding peak heights. Two arrays with dimen- 
sions consistent with the size of MH+ are used to 
record primary and transformed data and these en- 
able direct checking (look-up table) for the presence of 
any given real or transformed mass. Ion families 
‘We refer to fragment ion masses, rather than mass-to-charge ratios, 
in this article because the fragment ions are known to be singly 
charged. A multiply charged ion formed in the (floated) collision cell 
of a four-sector tandem machine would not appear at all in the 
fragment ion spectrum because it would not be simultaneously 
transmitted through the electric and magnetic sectors of MS-II dur- 
ing the linked scan [32] of these two fields. 
whose scores exceed a set threshold are recorded in 
the second array and indexed according to the mass 
of the y ion belonging to this family. Each y-centered 
family record contains the count of members, the sum 
of their peak heights, and a list of the types of ions 
found (an actual y ion does not need to be found in 
Table 2. The ion matrix shown depicts the transformation of 
the “seed” mass of 468 u (in bold) from a pepide with 
a protonated molecular ion of 1093 u 
a b c d ” w * Y z 
468 496 513 539 653 652 624 598 582 
440 468 485 511 681 680 652 626 610 
423 451 468 494 698 697 669 643 627 
397 1425 1442 1468 1724 1723 1695 1669 1653 
Rows within the ion matrix represent “ion families” as defined in 
the text. Ions types are listed at the top of each column. The 
symmetrical relationships of N- and C-terminal ion pairs should be 
noted. Figure 2 shows the matches found for ion families that 
include the peak at 468 u in the peptide spectrum from which this 
example was derived. 
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the data to establish a "y-center"). This transforma- 
tion continues for each new seed ion whose peak 
height remains above a cutoff that is either at the 
fiftieth percentile (default) or a value specified by the 
user. Duplication of effort is eliminated in the trans- 
formation step, by using the y mass of each family to 
test if that family has already been found (using 
another more abundant family member as the seed 
ion). A strategy has been described by Bartels [33] 
utilizing a similar transformation into what was 
termed a “sequence spectrum” but few details of 
actual sequence generation were provided. 
After our transformation has been completed, y- 
centers are then linked. A link is generated when two 
y-centers differ by the residue mass of an amino acid. 
Links are scored by the peak height and number of 
ions in each of the linked y-centers as well as by the 
similarity of ions observed. This last score is termed 
the “common ion count” and is the number of same 
type ions found in both sets. For example, two y- 
centers, m /z 650 = a, b, y, z + 1 and 765 = v, W, y, 
z + 1, have common ion count = 2 for the y and 
z + 1 ions in common and they are linked by Asp 
whose residue mass is 115. Transformation to “y-ion 
space” could also allow for calculation of the mass of 
unanticipated or modihed amino acids. This requires 
recognition of two y-cenfers that are strongly sup- 
ported yet yield poor sequence interpretations (i.e., 
have poor or missing links) through this mass region. 
In such a case the mass of the new amino acid is 
simply the difference between the two strongly sup- 
ported y-center masses. Current scoring protocols are 
poor, however, at recognizing such a link. At present, 
manual analysis of transformed data is the best way 
of locating a novel amino acid, in our experience. 
Once the y-centers have been linked, sequences are 
generated by tracing forward from low to high y-mass. 
Starting points can be restricted by knowledge of 
enzymatic conditions used in generating peptides. 
Tryptic peptides would most commonly be restricted 
to an Arg or Lys at the C-terminus, though this 
restriction would likely prevent successful interpreta- 
tion of a protein’s C-terminal peptide as well as any 
peptides derived from nonspecific cleavage. If not 
restricted by the user, sequences may begin with any 
of eighteen choices: the sixteen nonisobaric amino 
acids or one member of the isobaric pairs of Leu/Ile 
and Lys/Gln. The algorithm presently uses the single 
letter code for Leu, L, to denote Leu or Ile, and the 
single letter code for Lys, K, to denote Lys or Gln, 
and makes no attempt to differentiate within these 
pairs (see footnote 1). Modtied N- or C-terminal 
groups are allowed but must be indicated by the user 
to be considered in the IinaI sequences. Sequence 
tracing consists of recursively moving up in sequence 
by the predetermined links. Sequences are complete if 
they link to MH+ {the hnal y-center). Completed 
sequences are restored to include immonium and 
other low mass amino acid specihc ions and to ex- 
elude ions that fit a generic y-center but do not ht the 
specific sequence. An example of this would be the 
exclusion of a w ion from the lower side of a Gly lii 
because glycine has no side chain. Scores of com- 
pleted sequences include the count of sequence ions 
found, the sum of peak heights, and the sum of the 
common ion counts from the link scores. A further 
type of score is detailed in the Discussion. 
False leads are reduced by a back tracing routine 
that was added to prevent sequence tracing along 
paths that cannot be linked to MH+. This is accom- 
plished by hrst flagging those y-centers that are linked 
to MH+ by a single residue mass. Then in a single 
pass though the array of y-centers beginning at the 
high mass end and progressing downwards, the down 
links of each “flagged” y-center are flagged. This 
procedure will flag any y-center that can be completed 
but does not need to explore all the pathways by 
which completion can occur to do this. The tracing 
algorithm can then disregard links to y-centers that 
have not been “flagged” as being able to be com- 
pleted. This can have a large effect in reducing the 
time needed to complete the sequence tracing step. 
Completed sequences are written to an ASCII tie, 
as are lists of y-centers and y-center linkage data. 
These ties then serve to assist manual evaluation of 
the spectrum. 
Results 
Examples follow for the three major steps of our 
algorithm. The first example depicts the creation of 
y-centers. Figure 2 shows the various y-centers derived 
from the seed mass of 468 u which is actually a b type 
ion. The true fit is quickly recognized as the most 
likely based on the types of ions often found together 
in an ion family. Any pair of N- and C-terminal ions 
can trade identities in support of an alternative y- 
center. Two of the alternative ion famiIies illustrate 
this symmetry-based problem where a C-terminal ion 
(in this example the y and z + 1 ions) from the correct 
set trades its context with the b ion at 448 u. The 468 
u = a and 539 u = d fit results from the coincidence 
of a and d ions differing by the residue mass of the 
amino acid (Ala = 71) that separates these two b ions. 
The 468 u = w and 440 u = x match arises Tom the 
coincidence of 28 u separating this pair and a, b pairs. 
The final false signal of 468 u = d and 695 u = x is 
simple coincidence. In this example, six of nine possi- 
ble y-centers survive the discrimination step for fami- 
lies derived from 468 u. Rules to exclude some sets, 
such as the seldom observed d, x pair, have not yet 
been incorporated into our algorithm. Distinguishing 
between real and artifactual or coincidental y-centers 
is not trivial. Scoring options will be discussed below. 
Different y-centers are linked together when they 
differ in their y-masses by the residue mass of an 
amino acid. In Figure 3 the y-center 602 u is correctly 
linked up to 715 u by a leucine/isoleucine and linked 
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MH+ 
1093 
a d 
a b z+l Y 
d x 
x W 
t 
539 
P 
B 
Y b 
= 
9 2+1 b 
B ‘J 
+z 
468 
ry: lx 440 
695 
610 626 
300 500 700 900 
Mass 
Figure 2. An example of y-center transformation for the peak at 468 U, The “true” context is as a 
b ion with the corresponding ions at 440, 610, and 626 u htting as a, a + 1, and y ions, 
respectively, as shown in the sotid boxed set. Alternative interpretations of 468 u are shown in the 
dashed boxes with alternative ion family members. See the text for a discussion of symmetry-re- 
lated families. 
LlO 
down to 503 u by a valine. Correct links may some- 
times be deduced by similarity of ion content, as in 
this example. In many other instances, discrimination 
is not possible prior to consideration in the context of 
a completed sequence. This results in carrying many 
incorrect links. 
Correct sequences are generally accompanied by 
similar sequences with inversions and dipeptide 
substitutions. A peptide of M,901 gave the top 
four scoring sequences as SLDFYIR(46840), LSDF- 
YTR(45978), SLTYFDR(44490), and LSTYFDR(43628). 
The scores (in parentheses) are the sum of the peak 
heights of the sequence and immonium ions for the 
given sequences as reported by the program. In this 
example, the N-terminal pair inverts between the two 
best scoring candidates, which have similar scores. 
Residues 3-6 also invert in a less typical fashion. The 
order of the N-terminal pair is often difficult to deter- 
mine due to the presence of immonium ions and 
internal acyl or immonium fragments. Careful exami- 
nation of the spectrum might have enabled a best 
guess from among these possibilities based on the 
presence or absence of internal fragments while the 
small differences between the peak height sum scores 
alone would have been inadequate to confidently se- 
lect from among these candidates. From the same 
tryptic digest, however, the previously tin peptide 
gave the top scoring sequekes of KSLDFYTR(11603), 
KSDLFYTR(11252), KLSDFYTR(11250), and SLKD- 
FYTR(11132). By using this larger peptide in combina- 
tion with the smaller it was possible to conhdently 
assign the sequence KSLDFYTR. This spectrum is 
shown in Figure 4. The lysine on the N-terminus was 
chosen over the isobaric amino acid glutamine (by us, 
not by the algorithm, which does not attempt that 
distinction). In this example the choice derives from 
comparison of these two peptides and the fact that 
trypsin was used to digest the protein, indicating that 
the larger peptide was the result of incomplete envy- 
matic digestion. It should be noted that in the absence 
of the spectrum of the shorter peptide in this digest, 
one would have been tempted to reverse the argu- 
ment and call the lysine a glutamine because lysine 
would then represent a partial (unlikely?) digestion 
product. 
Discussion 
In ma& spectral sequencing, individual,amino acids 
are most simply assigned from successive sequence 
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Figure 3. Amino acid links between y-centers are detected by comparing y-center mass 
differences with known amino acid residue masses. Correct, as opposed to artifactual, links are 
often distinguished by similar types of sequence ions. In the example the ion family with y = 602 
u, also includes b, x, w, and Y ions as labeled immediately above the corresponding peaks. The 
best up and best down link y-families are shown and boxed. Ions labeled w’ represent R, = CH, 
(refer lo Figure 1 for explan&dn of R,). 
ions of the same type. For the peptide Gly-Ala-Asp, 
the difference between aI ion at m/z 30 and a2 at 
m/z 101 is 71 u and corresponds to Ala at position 2. 
The same difference of 71 is found between b1 
(m/z 58) and b, (m/z 129). In both cases the differ- 
ence is the addition of C,H,NO. Information about 
Ala2 could also be derived from b, and a2 if we knew 
that m/z 58 was a b ion and m /z 101 was an a ion. Of 
course, the difhculty is that we do not experimentally 
measure b or a character, we only measure the frag- 
ment ion masses (see footnote 2). Any strategy de- 
signed to deduce sequence from spectra must, in fact, 
label the individual ions, either by mathematical pat- 
tern recognition algorithms as a prelude to sequence 
assignment or, as is more common, by comparison 
with masses calculated from a proposed sequence. 
Our choice has been to attempt the pattern recogni- 
tion approach as a more direct path from data to 
sequence and one that may eventually allow for the 
automatic recognition of novel amino acids. In this 
pattern-based approach, identified ions are trans- 
formed to a consistent context from which sequence- 
based relationships between ions may be deduced. 
The pattern we use is that determined by the 
peptide nature of the sample, that is, the linear, 
polymeric repeat of amino acids. The algorithm sepa- 
rates the sequence-independent step of y-center de- 
tection from consideration of sequence-dependent 
relationships, the understanding of which is still 
evolving. Instead, it takes maximal advantage of what 
is known about the sample (that it is a polymer of 
alpha amino acids) before addressing the question of 
sequence. 
The linking process compares existing y families 
for linking rather than guessing y family extensions, 
and therefore can allow for more than the standard 
genetically encoded amino acids without slowing the 
linking process. This is because the linking step re- 
quires, at most, a single comparison between each 
pair of y-centers, not a loop through all extensions for 
each y-center. Each comparison results in a mass 
difference that is used directly in a look-up table. 
Look-up tables are used throughout our algorithm to 
realize signihcant speed advantages. Instead of using 
a loop to search a list of ions for the presence of a 
given mass, a look-up table allows one to directly 
inquire at that mass to determine whether it is pres- 
ent. This is accomplished both for real masses and for 
y-centers by using large arrays whose nth element is 
either zero, to indicate the absence of a mass n, or 
contains the address in memory of the data structure 
(pointer) that contains further information on that 
mass. In the case of linking, the look-up table holds 
the identities of residues with a particular mass. Links 
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x50 x5 
< > 
” 869.4 756.4 641.3 494.2 
XI u w 868.4 755.4 640.3 
* 927.4 840.4 727.4 612.3 
Y 901.4 814.4 ml.4 586.3 
Z+l 885.4 lBd 570.3 
Lys - SW - Phe - 
a 188.1 301.2 543.3 
331.2 230.1 
243.1 
465.2 302.1 201.1 
439.2 276.2 175.1 ME’ 
423.2 260.1 159.1 la9 
Tyr - Thr - ‘W 
827.d 
: 
216.1 444.2 
259.2 
Figure 4. A spectrum with completed sequence interpretation. In this example, the sets of z + 1, 
y, and x are quickly recognized. The dominance of C-terminal ions is readily accounted for by the 
presence of an Arg residue as the C-terminal amino acid. Currently onassigned, yet relatively 
abundant, are the ions at 316, 477, 6.55, and 661 u. The peak at 70 u could be assigned to Lys or 
Arg and so was not labeled. The peak at 129 u could be b, or the immonium ion for Arg and was 
also not labeled. Other amino acid specific low mass ions are labeled by uppercase single letter 
code. Ions denoted z, are in fact z,, + 1 ions according to the nomenclature presented in Table 1. 
are recorded in both the higher and lower mass y- 
centers in down and up links, respectively. This allows 
sequence tracing in both directions. 
Restrictions on amino acid composition are often 
possible from a survey of the low mass portion of a 
peptide’s CID spectrum. Amino acids that normally 
produce strong characteristic immonium ions are dis- 
allowed if their expected immonium ions are not pres- 
ent. Similarly, the presence of characteristic ions can 
be used to require their presence in completed se- 
quences. Disallowed residues are excluded in the link- 
ing steps, while required residues are used as a filter 
on completed sequences. Because the program is fast, 
requiring between 10 and 60 s depending on the 
number of sequences reported, reanalysis of a spec- 
trum without restrictions is quickly accomplished and 
is recommended to test the robustness of the best 
scoring sequence solutions. Additionally, restrictions 
can be used to reduce the number of sequences found. 
This can be enlightening even when an excluded 
amino acid is in the sequence of the peptide that is 
being analyzed! This seemingly strange result arises 
due to our ability to compare rapidly the best scoring 
sequences with and without restriction. 
The current version of our algorithm places two 
levels of restrictions on the number of completed 
sequences that are reported. The first restriction be- 
gins with the 1Olst sequence found and requires it to 
score better than 75% of the best current score. The 
second restriction is termination of sequence tracing 
after 400 sequences have been reported. These arbi- 
trarily chosen restrictions are in place to focus the 
user back to the parameters usable to limit the num- 
ber of sequences generated. The presence of such a 
large number of sequences indicates that too many 
y-centers are passing the initial discrimination step. 
One means of reducing the number of proposed se- 
quences is to increase the number of y-centers that are 
rejected. The two parameters usable for this are the 
number of family members that must be found and 
the minimum for their summed peak heights. A fur- 
ther way to decrease the number of y-centers is to 
reduce the number of ions used as seeds to generate 
the ion matrix. This in effect requires at least one of 
the y-center’s members to be above the peak height 
threshold for matrix generation. Another option is to 
use strong signals from within the originally proposed 
sequences to restrict the composition of reported se- 
quences. In this case the restrictions are not based on 
immonium ions but on strongly supported partial 
sequence(s) that may have been detected in the initial 
sequencing attempt. 
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Scoring can serve two goals in sequence analysis: 
to provide both relative and absolute rankings. A CID 
spectrum has two obvious dimensions: mass and ion 
abundance. Masses are used to identify individual 
peaks, and abundances are often used as a measure of 
importance in determining a sequence. Boolean de- 
scriptions are simplest: a peak at a given mass is 
either present or not, but this logic requires imposi- 
tion of an arbitrary abundance threshold below which 
signals do not count. Simple summation of ion abun- 
dances seems to address this difhculty by ‘weighting 
an ion’s presence by its abundance and therefore 
reduces thresholding effects, but directly correlating 
ion significance with abundance is dubious. There 
does not exist a compelling reason to assert that an 
ion that is ten times as abundant is ten times more 
meaningful or valuable for ranking alternative inter- 
pretations of data. Still, counts and abundance sums 
present information that remains free from bias po- 
tentially imposed by an interpretation scheme. In the 
method described by Johnson and Biemann [24], the 
principal score assigned to a sequence is the sum of 
the abundances of identihed ions normalized to total 
ion abundance. This ratio does describe the degree to 
which a spectrum has been fully interpreted, yet fails 
to weigh the degree of satisfaction applied to individ- 
ual ion assignments or to the completed pattern of 
sequence and nonsequence ions. A more complex 
scoring scheme was used to evaluate sequence exten- 
sions during their sequencing algorithm. The algo- 
rithm, described above, propagates partial sequences 
by one amino acid and evaluates the quality of ht to 
data. Extensions bear some similarity to our links. 
Extension scores are broken down into N-terminal 
and C-terminal scores that selectively exclude certain 
ion types if others are not found. For example, an Asn 
extension might yield a d ion but no score would be 
given it if the corresponding a ion was not also found. 
Extension scores are further modified based on prior 
subsequence, including potentially discounting exten- 
sion scores by 50% or 80% depending on the presence 
or absence of basic amino acids. The rationale given 
for this scoring scheme is that it is based on previous 
experience with CID spectra of known peptide se- 
quences. Dticulties arise in the use of arbitrary con- 
stants to modify scores and from the lack of rigor in 
evaluating the effects of these arbitrarily selected 
modifiers. Despite these concerns we currently lack a 
significantly better method for scoring sequence fits to 
CID data. 
We use a variety of scores to describe y-centers, 
links, and completed sequences. While attempts have 
been made to generate overall scores for ranking se- 
quences, the current emphasis is on simple descrip- 
tions to aid manual analysis of results ties. Scores for 
y-centers are the number of family members found, 
the sum of their peak heights, and a list of <ion types 
found, Link scores allow for the context applied by 
the link, revising the list of ions to those pertinent to 
the link. For example, an uplink by the residue mass 
of glycine would not include v or w ions in the lower 
mass y-cenfev or a d ion in the higher y-center. Con- 
textually correct ions are combined into a total count 
in both directions and the common ion count is calcu- 
lated. A last ad hoc link score is the product of the 
summed peak heights of both of a link’s y-centers and 
the square of the common ion count. The intent of 
this score is to emphasize links between similar sets of 
ions and it has proven useful in distinguishing be- 
tween otherwise similar scoring sequences. Another 
scoring scheme for emphasizing continuous series of 
same-type ions has been reported by Zidarov et al. 
[34]. The four sequence scores used in our work are 
the sum of peak heights of identified ions including 
relevant immonium ions, the count of identihed ions, 
the sum of the common ion count found in the links 
used in tracing the sequence, and the sum of the ad 
hoc link scores divided by the length of the peptide. 
We envision three major difficulties in producing 
adequate scores through simple combinations of ion 
abundances or ion counts. Different amino acids yield 
somewhat different fragments. Isoleucine and threo- 
nine can each produce two types of d ions and two 
types of w ions while glycine has no d, v, or w ions. 
For a given molecular weight, smaller amino acids 
give greater chain lengths and so a higher density of 
possible sequence ions. Lastly, different peptides of 
the same amino acid composition will not necessarily 
yield similar types or numbers of sequence ions due 
to, among other factors, the effects of a futed remote 
charge on observable fragment ions. The combination 
of these factors leads to the conclusion that what 
might be too few fragments to favor one sequence 
would be more than expected for another. 
An idealized score would need to consider exactly 
what a postulated sequence should produce in a CID 
spectrum. It should further compare results for all 
proposed sequences and produce a confidence index 
with absolute confidence in a single sequence yielding 
a score of 1. Consider two sequences, VDVLRAK and 
DWLRAK, identical except for transposition of the 
first two amino acids, having equal likelihood and 
exclusive of all other possibilities. Scores would then 
be VDVLRAK = 0.5; DWLRAK = 0.5; {D, V}VLRAK 
= 1. Creation of such a scoring scheme will require 
statistical evaluation of a large number of peptide CID 
spectra. This scheme will most likely require initial 
proposal of sequences consistent with the data, fol- 
lowed by a second step of predicting what data should 
result from a given sequence. 
Conclusions 
A distinctive difference between chemical (Edman 
degradation) and mass spectrometric sequencing is 
the nature of the data. In chemical sequencing, amino 
acids are removed one per cycle. Identihcation of each 
cycle’s amino acid derivative is by retention time 
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correlation with amino acid derivative standards. 
Nonstandard amino acids pose problems for that cy- 
cle’s analysis, yet do not prevent identification of 
subsequent cycles. Chromatographic constraints in re- 
solving normal standard mixtures preclude extensive 
preparation for rare amino acid derivatives. Edman 
sequencing chemistries (gas/liquid/solid phase) also 
suffer from sample losses that are cumulative and 
progressive, complicating or preventing analysis of 
residues near the peptide’s C-terminus. Edman se- 
quencing thus has the advantages of cycle-based anal- 
ysis, resulting in simple interpretation and confidence 
in partially correct answers. It has the disadvantages 
of inability to interpret residues for which a standard 
had not been evaluated, lack of redundancy, which 
provides consistency checks, and difficulty in com- 
pleting the analysis of the entire peptide. 
In contrast to chemical sequencing, mass spectral 
sequencing acquires data from the whole peptide si- 
multaneously, providing checks on the completeness 
of a determined sequence through redundancy and 
complementarity. This redundancy is at the expense 
of greater complexity. A high level of redundancy 
representing a small region of sequence can rob a 
spectrum of other observable sequence ions and, due 
to this competition, result in incomplete sequence 
information. Mass measurement does not require ex- 
plicit preparation for modified or rare amino acids 
prior to data collection. 
Pattern matching schemes for interpretation of mass 
spectrometric data have been reported previously 
[35-381. While general attempts have failed to meet 
expectations, some programs have proven quite reli- 
able. The success of most of these programs has been 
attributed to restriction of the class of compound 
being analyzed. Peptides certainly represent a special 
class of compounds in this sense. 
The current implementation of our algorithm has 
proved very good at interpreting certain classes of 
peptide spectra, especially those obtained from tryptic 
digests, but has also proved useful with peptides 
derived from S. azmus V8 and other proteases as well 
as naturally occurring peptide hormones. An excellent 
example is a tryptic peptide derived from a test pep- 
tide used to compare sequencing techniques [39]. The 
correct sequence of this tryptic peptide (ALFHGR) 
was determined and reported in less than 15 s by 
using the default parameters. The failure to interpret 
the complete structure of the undigested peptide can 
readily be attributed to a lack of sequence ions de- 
rived from some amino acids. In short, the data did 
not completely document the structure. Analysis of 
the tandem data from the undigested peptide did, 
however, predict an internal arginine residue and 
predict the size of tryptic peptides to be obtained on 
digestion. Thus, while a complete answer was not 
obtainable from the CID spectrum, partial analysis did 
suggest a plan to complete the characterization of the 
peptide. It must be noted that determination of the 
test peptide sequence was primarily performed by 
manual analysis of the liquid secondary ion mass 
spectrum (LSIMS) and CID on both the whole and 
digested peptides. Automated integration of data ob- 
tained from initial fragmentation in the LSIMS into 
the sequencing process would prove to be a powerful 
approach. The simpler fragmentation patterns some- 
times found in the LSIMS can Iead to better restric- 
tions on the identity of peaks also present in the CID 
spectrum. Further simplification occurs for the hrst 
and last amino acids in the sequence, as the high 
mass end of LSI mass spectra is not as populated by 
side chain losses as are CID spectra. One of the 
strongest features of our program is its ability to 
quickly identify reliable partial interpretations of data. 
Strategies for conhdent completion of sequence as- 
signments can then be based on the weakest stmc- 
tural clues presented and ways available to improve 
confidence in those regions. 
A single pass pattern recognition is used in the 
program described in this article. A promising alterna- 
tive would be a progressive refining of ion labeling. 
This might work in the following fashion. The first 
pass step described above would detect candidate 
y-centers. Strongly represented y-centers that are not 
mutually exclusive would be identified. Mutually ex- 
clusive means either through coinclusion of peaks or 
by virtue of being unlinkable by an amino acid (such 
as centers 44 u apart). The identities of the ions within 
these families would be hed as “known.” A second 
pass of y-center detection would then not use the 
“known” ions in alternative contexts. This approach 
could eliminate some of the symmetry problems 
demonstrated in Figure 2 and thereby diminish the 
number of false y-centers considered during linking 
and sequence tracing. 
It remains to understand and then use the more 
subtle patterns present in CID spectra of peptides. 
Some of the patterns that show the greatest chance of 
providing useful information involve the increase in 
abundance of certain sequence ion series depending 
on the positioning and relative pKas of basic side 
chains within the peptide being analyzed. An addi- 
tional hope is to assign probabilities of observing 
certain ion types for cleavages between specific amino 
acid pairs. Further improvement in our ability to pre- 
dict spectra based on sequence will be used to im- 
prove scoring. Accurate predictions will eventually 
result in scoring strategies based more on consistency 
with expectation, rather than relative strength of sig- 
nal. We beIieve that this level of analysis will ulti- 
mately be needed to generate confidence scores for 
ranking peptide sequence matches in any meaningful 
way. 
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